Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Infectious disease: Vaccine preventable diseases
  • Remove this filter Infectious disease: Sexually transmitted infections
  • Infectious disease
    • Vaccine preventable diseases (175)
    • Sexually transmitted infections (175)
    • Viral hepatitis (125)
    • Hepatitis B (119)
    • HIV infection (82)
    • Human immunodeficiency virus infection (82)
    • Acquired immunodeficiency syndrome (AIDS) (82)
    • Hepatitis C (73)
    • Respiratory diseases (67)
    • Tuberculosis (58)
    • Food- and waterborne diseases (48)
    • Hepatitis (40)
    • Hepatitis A (30)
    • Influenza (24)
    • Zoonosis (21)
    • Mosquito-borne diseases (19)
    • Syphilis (15)
    • Gonorrhoea (14)
    • Chlamydia infection (14)
    • Dengue (13)
    • Measles (12)
    • Malaria (11)
    • Rubella (11)
    • Healthcare-associated infections (11)
    • German measles (11)
    • Nosocomial infections (11)
    • Influenza in humans, seasonal (10)
    • Seasonal influenza (10)
    • Flu (10)
    • Salmonellosis (9)
    • Viral haemorrhagic fever (9)
    • Chikungunya virus disease (9)
    • Emerging disease (8)
    • Vector-borne disease (8)
    • Ebola haemorrhagic fever (7)
    • Diphtheria (7)
    • West Nile virus infection (7)
    • Avian influenza virus (7)
    • Invasive meningococcal disease (7)
    • Poliomyelitis (7)
    • Multidrug-resistant tuberculosis (7)
    • Zoonotic influenza (7)
    • Meningococcal disease (7)
    • Campylobacteriosis (6)
    • Rabies (6)
    • Yellow fever (6)
    • Cholera (6)
    • Hepatitis E (6)
    • Listeriosis (6)
    • Pertussis (6)
    • Influenza in humans, avian origin (6)
    • Avian influenza in humans (6)
    • Pneumococcal disease (6)
    • Influenza A (H9N2) (6)
    • Invasive pneumococcal disease (6)
    • S. pneumoniae (6)
    • Whooping cough (6)
    • Streptococcus pneumoniae (6)
    • Severe acute respiratory syndrome (SARS) (5)
    • Escherichia coli infection (5)
    • Anthrax (5)
    • Tick-borne diseases (5)
    • Mumps (5)
    • Echinococcosis (5)
    • Shiga toxin producing Escherichia coli (STEC) infection (5)
    • Hydatidosis (5)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (5)
    • Haemophilus infection (5)
    • Haemophilus influenzae type b (HiB) infection (5)
    • Invasive Haemophilus influenzae disease (5)
    • Verotoxigenic Escherichia coli infection (5)
    • Cryptosporidiosis (4)
    • Smallpox (4)
    • Botulism (4)
    • Shigellosis (4)
    • Plague (4)
    • Q fever (4)
    • Legionnaires’ disease (4)
    • Leptospirosis (4)
    • Marburg haemorrhagic fever (4)
    • Rift Valley fever (4)
    • Lassa fever (4)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (4)
    • Nephropathia epidemica (4)
    • Marburg virus diseases (4)
    • Hantavirus infection (4)
    • Ebola outbreak - North Kivu, Ituri, DRC (4)
    • Crimean-Congo haemorrhagic fever (4)
    • Giardiasis (4)
    • Hospital-acquired infections (3)
    • Surgical site infections (3)
    • Human papillomavirus infection (2)
    • Tetanus (2)
    • Varicella (2)
    • Cutaneous warts (2)
    • Middle East respiratory syndrome coronavirus (2)
    • Rotavirus infection (2)
    • Coronavirus (2)
    • Chickenpox (2)
    • Yersiniosis (1)
    • Trichinellosis (1)
    • Zika virus disease (1)
    • Drug-resistant tuberculosis (1)
    • Extrapulmonary tuberculosis (1)
    • Lymphogranuloma venereum (1)
    • Guillain-Barré syndrome (1)
    • Vibrio (1)
  • Public health area
    • Surveillance (73)
    • Prevention and control (44)
    • Disease prevention (44)
    • Prophylaxis (44)
    • Public health threat (22)
    • Outbreak (22)
    • Threats and outbreaks (22)
    • Epidemiology (19)
    • Scientific advice (18)
    • Determinant (14)
    • Antimicrobial resistance (11)
    • Antibiotic resistance (11)
    • Immunisation (10)
    • Vaccination (10)
    • Active immunisation (10)
    • Migrant health (6)
    • Burden of communicable diseases (5)
    • Microbiology (4)
    • Pregnant women (4)
    • HIV testing (3)
    • Laboratories (3)
    • Preparedness (3)
    • Health inequality (3)
    • Epidemic (3)
    • Health communication (3)
    • Mass gathering (2)
    • Diagnostic test (2)
    • Transmission of disease (1)
    • Laboratory capacity (1)
    • Injecting drug users (IDUs) (1)
    • Intravenous drug users (1)
    • Control campaign (1)
    • Multidrug resistance (1)
    • Travellers' health (1)
    • Infectious diseases on aircrafts (1)
    • People who inject drugs (PWID) (1)
    • Public health response (1)
    • Preventive measure (1)
    • Epidemic intelligence (1)
    • Country cooperation (1)
    • Biosafety (1)
    • Blood safety (1)
  • Country
    • Europe (88)
    • Africa (4)
    • Americas (3)
    • Asia (1)
    • Indian Ocean (1)
  • Type
    • Publication (107)
    • Peer-reviewed publication (37)
    • Data (28)
    • Surveillance report (17)
    • Event (16)
    • Technical report (15)
    • News (15)
    • Graph (8)
    • Campaign (7)
    • Corporate publication (7)
    • Public health guidance (7)
    • Technical guidance (7)
    • Table (6)
    • News story (5)
    • Mission report (4)
    • Map (4)
    • Tool (4)
    • Literature review (3)
    • Infographic (3)
    • Meeting report (2)
    • Systematic review (2)
    • Risk assessment (2)
    • ECDC comment (2)
    • Presentation (2)
    • External link (2)
    • Toolkit (1)
    • Epidemiological update (1)
    • Press release (1)
    • Expert meeting (1)
    • Video (1)
    • Facts (1)
    • Networks and partnerships (1)
    • Corporate information (1)
    • Platform (1)
  • Page 1 of 18 // 175 Results found
    • Sort by:

News

Know your status: get tested during European Testing Week

News - 22 Nov 2019

On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.

  • EU/EEA
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • HIV testing
  • Sexually transmitted infections
  • Viral hepatitis

Data

Surveillance systems overview for 2018

Table - 24 Oct 2019

This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2018.

  • Anthrax
  • Botulism
  • Campylobacteriosis
  • Chikungunya virus disease
  • Chlamydia infection
  • Cholera
  • Crimean-Congo haemorrhagic fever
  • Cryptosporidiosis
  • Dengue
  • Diphtheria
  • Ebola haemorrhagic fever
  • Echinococcosis
  • EU/EEA
  • Giardiasis
  • Hantavirus infection
  • Healthcare-associated infections
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Influenza
  • Invasive Haemophilus influenzae disease
  • Lassa fever
  • Leptospirosis
  • Listeriosis
  • Malaria
  • Marburg haemorrhagic fever
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Plague
  • Pneumococcal disease
  • Poliomyelitis
  • Q fever
  • Rabies
  • Rift Valley fever
  • Salmonellosis
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Surveillance
  • Verotoxigenic Escherichia coli infection
  • West Nile virus infection

Publication

Communicable disease threats report, 8-14 September 2019, week 37

Publication - 13 Sep 2019

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 8-14 September 2019 and includes updates on Ebola virus disease, Group A streptococcus infection, Neisseria gonorrhoeae, Vibrio growth in the Baltic Sea, measles and West Nile virus.

Communicable disease threats report, 8-14 September 2019, week 37 - EN - [PDF-2.47 MB]
  • Ebola outbreak - North Kivu, Ituri, DRC
  • Europe
  • Gonorrhoea
  • Measles
  • Public health threat
  • Vibrio
  • West Nile virus infection

News

Targeted testing for viral hepatitis: Europe’s persistent public health challenge

News story - 25 Jul 2019

Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.

  • EU/EEA
  • Hepatitis B
  • Hepatitis C
  • Public health response
  • Surveillance
  • Viral hepatitis

Peer-Reviewed Publication

Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review

Jul 2019 - Euro Surveill. - 24(30)

Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.

  • EU/EEA
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Immunisation
  • Pregnant women
  • Prevention and control
  • Transmission of disease
  • Viral hepatitis

Event

World Hepatitis Day 2019

Campaign
28 Jul 2019

World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.

  • Health communication
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Hepatitis E
  • Viral hepatitis

Peer-Reviewed Publication

Can economic indicators predict infectious disease spread? A cross-country panel analysis of 13 European countries

Jul 2019 - Scand J Public Health -

Hunter, P.R., Colón-González, F.J., Brainard, J., Majuru, B., Pedrazzoli, D., Abubakar, I., Dinsa, G., Suhrcke, M., Stuckler, D., Lim, T.-A., Semenza, J.C.

  • Diphtheria
  • EU/EEA
  • Gonorrhoea
  • Hepatitis A
  • Hepatitis B
  • Measles
  • Meningococcal disease
  • Pertussis
  • Preparedness
  • Prevention and control
  • Salmonellosis
  • Surveillance
  • Syphilis

Publication

Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019

Risk assessment - 2 Jul 2019

In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.

Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019 - EN - [PDF-1.13 MB]
  • Diphtheria
  • Food- and waterborne diseases
  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Mass gathering
  • Measles
  • Meningococcal disease
  • Middle East respiratory syndrome coronavirus
  • Mumps
  • Poliomyelitis
  • Public health threat
  • Rabies
  • Rubella
  • Saudi Arabia
  • Tetanus
  • Travellers' health
  • Vaccine preventable diseases
  • Vector-borne disease

Publication

Hepatitis B - Annual Epidemiological Report for 2017

Surveillance report - 17 Jun 2019

In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population.

Hepatitis B - Annual Epidemiological Report for 2017 - EN - [PDF-1.04 MB]
  • EU/EEA
  • Hepatitis B
  • Surveillance

News

Chronic hepatitis B infections on the rise since 2008

News story - 17 Jun 2019

In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.

  • EU/EEA
  • Hepatitis B
  • Prevention and control
  • Surveillance
  • Viral hepatitis

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us